J&J | JNJ - Current Assets


J&J reported $56.35B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
AbbVie USD 33.67B 140M Jun/2026
Abbott USD 25.51B 488M Mar/2026
Amgen USD 34.96B 3.49B Jun/2026
AstraZeneca USD 27.97B 1.65B Jun/2026
Baxter International USD 6.99B 142M Jun/2026
Bayer EUR 33.64B 1.66B Jun/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Biogen USD 7.58B 278.7M Sep/2026
Boston Scientific USD 7.97B 712M Jun/2026
Bristol-Myers Squibb USD 29.77B 1.19B Sep/2026
CONMED USD 682.04M 6.37M Sep/2026
Cooper Companies USD 2.28B 18.3M Jun/2026
Dexcom USD 4.09B 245.1M Jun/2026
Edwards Lifesciences USD 6.82B 590.2M Jun/2026
Eli Lilly USD 65.26B 591M Sep/2026
Gilead Sciences USD 12.53B 6.11B Jun/2026
GlaxoSmithKline GBP 17.9B 336M Sep/2026
Globus Medical USD 2.22B 17.39M Jun/2026
Insulet USD 1.85B 139.6M Jun/2026
Integra LifeSciences USD 1.19B 1.54M Sep/2026
Intuitive Surgical USD 10.65B 1.68B Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Medtronic USD 24.39B 397M Jun/2026
Merck USD 36.68B 1.66B Jun/2026
Merit Medical Systems USD 1.11B 10.46M Jun/2026
Novartis USD 27.35B 744M Jun/2026
Pfizer USD 41.36B 1.46B Jun/2026
Regeneron Pharmaceuticals USD 18.45B 236.8M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 31.52B 1.36B Jun/2026
Stryker USD 14.42B 1.08B Jun/2026
Tandem Diabetes Care USD 804.64M 82.46M Jun/2026
Teva Pharmaceutical Industries USD 13.76B 50M Jun/2026
Vertex Pharmaceuticals USD 12.54B 813.4M Jun/2026
Zimmer Biomet Holdings USD 5.1B 134.2M Jun/2026
Zoetis USD 6.36B 118M Jun/2026